home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc.

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Website: viatris.com

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture PR Newswire Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities a...

VTRS - Viatris' Mylan no longer subject of DOJ antitrust probe on drug price-fixing

2024-07-02 08:07:59 ET Viatris’ ( NASDAQ: VTRS ) Mylan unit is no longer a subject of DOJ’s antitrust investigation in the generic drug industry, the pharmaceutical firm said on Tuesday.... Read the full article on Seeking Alpha For further details see:...

VTRS - U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...

VTRS - S&P 500 Four Under Five

2024-06-30 00:30:00 ET Summary The S&P 500's strong first half, with gains exceeding 15%, has pushed its valuation even higher. Four stocks in the S&P 500 have a lower earnings multiple than the 4.9 percentage point gap between the average and median multiple of the index&...

VTRS - Viatris Named to TIME's World's Most Sustainable Companies 2024 List

Viatris Named to TIME's World's Most Sustainable Companies 2024 List PR Newswire PITTSBURGH , June 25, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's W...

VTRS - Goldman's top 50 high Sharpe Ratio stocks

2024-06-25 10:29:34 ET More on S&P 500 Index: Odds For A Soft Landing Improve S&P 6300? Is That Outside The Realm Of Possibility? Nervous Calm Hangs Over The Markets Nasdaq, S&P, Dow are mixed after selloff in tech stocks Is the Nvidia-led...

VTRS - 50 S&P stocks with biggest exposure to international sales - Goldman Sachs

2024-06-22 12:45:00 ET With the 2024 U.S. presidential elections heating up next week in the form of the first debate, Goldman Sachs' portfolio strategy research team took a look at American companies which have the biggest exposure to domestic and international sales.... Read the ful...

VTRS - How the (VTRS) price action is used to our Advantage

2024-06-15 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

VTRS - Regeneron wins injunction blocking Samsung Bioepis from launching generic Eylea

2024-06-14 12:44:17 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Tran...

VTRS - Viatris: Revenues, Debt, Valuation And Strategy Under The Microscope

2024-06-13 12:38:50 ET Summary Viatris presents a unique equation to prospective investors. The stock is cheap on a price to sales / price to earnings ratio, but the business has been shrinking. Debt is massive - but cash flow is strong, and divestitures have already earned &g...

Next 10